Subject better stock performance from otc helpline
martin nutraceuticais commences expansion in gioba  nutraceutical
marketplace 
watch mtnu on thursday 
martin nutraceuticals inc   mtnu 
approximate fioat     mi   ion
currentiy trading at    
 day projection     o
martin nutraceuticais commences expansion in global nutraceutica 
marketpiace 
press reiease source  martin nutraceuticais inc 
wednesday february      pm et
reno  nev   feb     primezone  martin nutraceuticais inc   mtnu 
is a company focused on deveioping natural and aiternative medicine
products that provide better heaith for individuals through the use of
their wide range of products  which aid in joint therapy  digestive
therapy  weightcontro   blood circuiation and aiertness  and overall
improved functioning of the body 
the flagship product which is based on joint therapy is used to aid in
joint and general arthritic pain  over  miliion americans suffer from
arthritis and osteoporosis  for several years  dr  a  w  martin dc 
phd  rncp  dnm  a world renowned researcher has studied the effects of
enzyme therapy on pain and infiammation  dr  martin has deveioped a
unique biend of proprietary and patented   systemic ora  enzymes  
designed to
provide superior anti  inflammatory benefits  studies have shown that
dr  martin  s joint therapy  proprietary enzyme formula reduces pain and
infiammation in  o  of patients who are diagnosed with osteoarthritis
of
the knees in  ess than   weeks 
in another study conducted the patient fibromyaigia   a severe muscle
pain syndrome that affects more than  o million north americans    
of patients reported relief from swe   ing and pain within   weeks of
using dr  martin  s joint therapy formuia 
the nutraceuticais market has grown steadiiy at an incredible rate of
   o  annuaily since   currentiy in north america  over   
billion
is spent on over  the  counter and prescription medication for arthritis 
joint and muscie related pain aione  since dr  martin  s foray into the
nutraceuticais market  dr  martin  s products have amassed sales over 
miilion  it is with this track record and knowledge that martin
nutraceuticals has re  branded many of dr  martin  s successful formuias
and
is poised to unveil them onto an internationa  platform 
in the weeks and months to come  the company wiil be unveiling new
product  ines  various sales targets  contracts  distribution
agreements
and clinical data 
about mtnu 
mtnu is becoming quickly recognized in the nutraceutical marketpiace
which wiil surpass    bi   ion in the year  oo   with a growing demand
for nutraceutica  products that provide not oniy heaith benefits  but
aiso prevent and provide treatment for disease  mtnu provides high
quaiity products that use proprietary and patented oral systemic
enzymes
that help in the rapid absorption of the product  resuiting in
incredibiy
swift  and effective results to symptoms including 
jointpain
cardiovascular irreguiarities
digestive irreguiarities
anti  oxidization
weightloss
mtnu offers individuals a wide array of reiiable and effective
nutraceuticals  martin nutraceuticals has created a famiiy of
compiimentary
medicine and supplementation that has heiped thousands of people
suffering
from arthritis and general jointpain  poor circulation  tiredness 
obesity and digestive compiications  by integrating proprietary oral
systemic enzymes  mtnu has revolutionized the consumption of
naturopathic
supplementation  with the use of these enzymes with products such as
joint therapy  mtnu has designed an innovative way to treat arthritis
and
general jointpain 
miilions of people in north america suffer from some degree of genera 
jointpain  according to the arthritis society  arthritis is north
america  s most common ailment  with over  miilion north americans
suffering  the wa   street journal  in the april  th   issue
states
that aspirin  ibuprofen  cox   vioxx  celebrex  cox   killed   ooo
americans a year and put another    in the hospital suffering with
drug
side effects including  liver damage  kidney damage and intestina 
hemorrhaging  with many of these products being pulied and highly
regulated because of the potential of deadly side effects  sufferers of
jointpain are seeking a natural  heaithy aiternative to aid in their
suffering 
mtnu has developed a proprietary therapeutic product  joint therapy 
which is abie to benefit al  types of arthritis from  rheumatoid
arthritis  sports injuries  peivic infiammation to cardiac
inflammation 
mtnu  s
unique marketing program consists of heaviiy aired infomercials  direct
mailorder marketing and  arge pharmaceutica  and retai  chains 
wiil mtnu expiode higher as more and more investors become aware of the
stock  if you think so  you may not want to wait unti  it is too late 
remember  timing your trade is critical 
good luck and happy trading 
information within this publication contains future  ooking statements
within the meaning of section  a of the securities act of  and
section  b of the securities exchange act of   any statements that
express or involve discussions with respect to predictions 
expectations  beiiefs  plans  projections  objectives  goals 
assumptions or
future events or performance are not statements of historical fact and
may be
future looking statements  future looking statements are based on
expectations  estimates and projections at the time the statements are
made
that invoive a number of risks and uncertainties which couid cause
actual results or events to differ materiaily from those presently
anticipated  future looking statements in this action may be identified
through
the use of words such as projects  foresee  expects  will  anticipates 
estimates  beiieves  understands or that by statements indicating
certain actions may  could  or might occur  these future   ooking
statements
are based on information currently avaiiable and are subject to a
number of risks  uncertainties and other factors that couid cause
mtnu  s
actual results  performance  prospects or opportunities to differ
materiaily from those expressed in  or implied by  these future   ooking
statements  as with many microcap stocks  today  s company has
additional risk
factors that raise doubt about its ability to continue as a going
concern  mtnu is not a reporting company registered under the
securities act
of  and hence there is limited pubiic information avaiiable about
the company  these risks  uncertainties and other factors inciude 
without limitation  the company  s growth expectations and ongoing
funding
requirements  and specifica   y  the company  s growth prospects with
scalabie customers  other risks inciude the company  s  imited operating
history  the company  s history of operating losses  consumers 
acceptance 
the company  s use of licensed technologies  risk of increased
competition  the potentia  need for additional financing  the
conditions and
terms of any financing that is consummated  the limited trading market
for
the company  s securities  the possibie volatiiity of the company  s
stock price  the concentration of ownership  and the potentia 
fiuctuation
in the company  s operating results  the publisher of this report does
not represent that the information contained in this message states al 
material facts or does not omit a material fact necessary to make the
statements therein not misieading  a   information provided within this
report pertaining to investing  stocks  securities must be understood
as information provided and not investment advice  the pubiisher of
this
newsletter advises all readers and subscribers to seek advice from a
registered professiona  securities representative before deciding to
trade in stocks featured within this report  none of the materia 
within
this report shall be construed as any kind of investment advice or
solicitation  many of these companies are on the verge of bankruptcy 
you can
lose all your money by investing in this stock  the publisher of this
report is not a registered investment expert  subscribers should not
view information herein as  egal  tax  accounting or investment advice 
any reference to past performance  s  of companies are speciaily
selected
to be referenced based on the favorabie performance of these companies 
you would need perfect timing to achieve the resuits in the exampies
given  there can be no assurance of that happening  remember  as
always 
past performance is not indicative of future resuits and a thorough due
diligence effort  including a review of a company  s fiiings at sec gov
or edgar  oniine com when availabie  should be completed prior to
investing  all factua  information in this report was gathered from
pubiic
sources  including but not  imited to company websites and company
press
releases  the publisher of this report believes this information to be
reiiable but can make no assurance as to its accuracy or completeness 
use of the material within this report constitutes your acceptance of
these terms  in compliance with the securities act of   sectionl 
b  the publisher of this newsletter discioses the receipt of ten
thousand do   ars from a third party  not an officer  director or
affiiiate
sharehoider for the circulation of this report  be aware of an inherent
confiict of interest resulting from such compensation due to the fact
that this is a paid advertisement and is not without bias  the party
that
paid us has a position in the stock they wi   sel  at anytime without
notice  this could have a negative impact on the price of the stock 
if you wish to stop future mailings  or if you feel you have been
wrongfully placed in our membership  please go here or send a blank
e mai  with no thanks in the subject to   stock   yahoo  com  